Page last updated: 2024-11-05

thalidomide and Plica Syndrome

thalidomide has been researched along with Plica Syndrome in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, W2
Zhong, LQ1
Li, WD1
Wu, SJ1
Song, HM1
Setty, AR1
Robinson, D1

Other Studies

2 other studies available for thalidomide and Plica Syndrome

ArticleYear
Thalidomide may be an effective drug for Blau syndrome: a case report.
    Annals of palliative medicine, 2022, Volume: 11, Issue:7

    Topics: Arthritis; Female; Humans; Nod2 Signaling Adaptor Protein; Sarcoidosis; Synovitis; Thalidomide; Uvei

2022
A 62-year-old man with wrist and hand pain.
    Arthritis and rheumatism, 2009, Jan-15, Volume: 61, Issue:1

    Topics: Amyloidosis; Anti-Inflammatory Agents; Arthralgia; Colchicine; Dexamethasone; Diagnosis, Differentia

2009